Latest news with #UnitedHealthGroupIncorporated
Business Upturn
4 days ago
- Business
- Business Upturn
Class Action Filed Against UnitedHealth Group Incorporated (UNH) – July 7, 2025 Deadline to Join – Contact Levi & Korsinsky
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in UnitedHealth Group Incorporated ('UnitedHealth Group Incorporated' or the 'Company') (NYSE: UNH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of UnitedHealth Group Incorporated investors who were adversely affected by alleged securities fraud between December 3, 2024 and April 16, 2025. Follow the link below to get more information and be contacted by a member of our team: UnitedHealth Group Incorporated Lawsuit Submission Form UNH investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) UnitedHealth had, for years, engaged in a corporate strategy of denying health coverage in order to boost its profits, and ultimately, its share price; (2) this anti-consumer strategy resulted in regulatory scrutiny against UnitedHealth, which ultimately resulted in the murder of Brian Thompson; (3) animus towards UnitedHealth was such that, subsequent to the murder of Mr. Thompson, many Americans openly celebrated his demise, expressed admiration for his accused killer, and/or otherwise demanded that UnitedHealth change its strategy even if they condemned Mr. Thompson's killing; (4) the foregoing regulatory and public outrage caused UnitedHealth to change its corporate practices; (5) notwithstanding the foregoing, UnitedHealth recklessly stuck with the guidance it issued the day before Thompson's murder, which was unrealistic considering the Company's changing corporate strategies; and (6) as a result, defendants' public statements were materially false and/or misleading at all relevant times. WHAT'S NEXT? If you suffered a loss in UnitedHealth Group Incorporated during the relevant time frame, you have until July 7, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY 10004 [email protected] Tel: (212) 363-7500Fax: (212) 363-7171
Yahoo
5 days ago
- Business
- Yahoo
UnitedHealth Group Incorporated (UNH): A Bull Case Theory
We came across a bullish thesis on UnitedHealth Group Incorporated (UNH) on FluentInQuality's Substack. In this article, we will summarize the bulls' thesis on UNH. UnitedHealth Group Incorporated (UNH)'s share was trading at $295 as of 27th May. UNH's trailing and forward P/E were 12.35 and 12.92 respectively according to Yahoo Finance. alexkich/ UnitedHealth Group is well-positioned as Medicare Advantage grows, with its Optum Health division reaching nearly 100 million consumers annually, reflecting massive scale but showing recent stagnation likely due to market saturation, post-pandemic shifts, and a focus on value-based care. Leadership changes saw the return of former CEO Stephen Hemsley, whose long tenure and deep involvement have driven significant company growth, now reinforced by a substantial equity stake that aligns his interests with shareholders. Employee sentiment, based on thousands of Indeed reviews, is generally positive, highlighting competitive pay, mission alignment, career growth opportunities, and work-life balance, though communication from management could improve. UnitedHealth's financial performance shows strong value creation, with return metrics at the high end for healthcare insurers despite the capital-intensive nature of the industry. Insider and institutional ownership indicate confidence, with major executives and directors holding meaningful stock positions and many institutions increasing their shares. The company's competitive advantages stem from its unmatched scale, extensive provider network, and vertical integration via Optum, which spans insurance, care delivery, pharmacy benefits, and data analytics, creating high switching costs and operational efficiencies. Although its brand faces some reputational challenges, UnitedHealth leverages its vast network and embedded contracts to maintain pricing power and market dominance. The healthcare industry itself is on a robust growth trajectory, with U.S. spending projected to rise from $4.5 trillion in 2024 to $6.8 trillion by 2032, driven by aging demographics, chronic disease, and increased managed care adoption, providing strong secular tailwinds for UnitedHealth's continued expansion and innovation. Previously, we have covered UnitedHealth Group Incorporated (UNH) in April 2025, wherein we summarized a bullish thesis by Oguz Erkan on Substack. The author highlighted its position as a resilient healthcare compounder, benefiting from the defensive nature of health insurance and strong pricing power even during economic downturns. Despite recent challenges and skepticism, UNH's vertically integrated model through Optum supported consistent revenue growth of 11% annually, with a fair valuation reflected in its forward P/E of 20, making it an attractive long-term investment, especially on price dips below $550. UnitedHealth Group Incorporated (UNH) is on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 139 hedge fund portfolios held UNH at the end of the first quarter which was 150 in the previous quarter. While we acknowledge the risk and potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than UNH but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 days ago
- Business
- Yahoo
UnitedHealth Group Incorporated (UNH): Jim Cramer Says Lots Of Insider Buying Is A Great Sign
We recently published a list of . In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other stocks that Jim Cramer discusses. UnitedHealth Group Incorporated (NYSE:UNH), the largest health insurer in America, has been a regular feature of Cramer's morning show lately. The stock is down by a whopping 41% year-to-date due to a disastrous earnings report in April. The earnings report was one of the worst in UnitedHealth Group Incorporated (NYSE:UNH)'s history, and it sent the shares tanking by an unbelievable 27%. The days after the report weren't kind to the stock either as multiple reports claimed that it was being investigated. Cramer commented on one such report and ratings action from HSBC: 'Oh UNH is up. A senior healthcare professional giving advice to a patient in a clinic. In fact, Cramer's been citing insider buys as evidence of robust management at UnitedHealth Group Incorporated (NYSE:UNH) for quite some time. Here are his recent remarks: 'People sell things for many reasons, right. They get divorced, I don't know about that. They get maybe something happens in their family, they need money. But David, why do they buy? Sometimes they buy because there's a bargain. Now typically these insiders, maybe they buy like 1500 shares. Well how about if you bought, you're Stephen Hemsley, returning CEO, who acquired 86,000 shares at 288. That's pretty, you know 25 mil. Overall, UNH ranks 4th on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of UNH, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28-05-2025
- Business
- Yahoo
Jim Cramer on UnitedHealth Group (UNH): 'I Have to Take a Pass'
We recently published a list of . In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other stocks that Jim Cramer discusses. A caller inquired if UnitedHealth Group Incorporated (NYSE:UNH) stock presents a buying opportunity or has it become a value trap. In response, Cramer said: 'Look, I think, now this is a really tricky one because my rules say that even if I like that stock, and I gotta tell you, I think that Mr. Hemsley is fantastic, even if I like that stock, if there is a Justice Department inquiry, if there are problems with the government, I have to take a pass. Because more often than not, I've been hurt when I speculate.' A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group (NYSE:UNH) is a healthcare company that provides health plans, care services, pharmacy benefits, and health management programs. The company also offers software, data solutions, and consulting to healthcare organizations. Appearing on Squawk on the Street on May 21, Cramer said: 'Oh UNH is up… The things that they, I mean I thought that this was about as strongly denied, they've not denied the other stuff… Oh the HSBC, that's really early… Well Mr. Hemsley bought so much stock. You see those insider buys, from smart people. Those are not idle. It's not an idle buy. . .I think Hemsley's money. He's money. He's very good.' Overall, UNH ranks 3rd on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of UNH as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
27-05-2025
- Business
- Yahoo
Jim Cramer on UnitedHealth Group (UNH): 'I Have to Take a Pass'
We recently published a list of . In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other stocks that Jim Cramer discusses. A caller inquired if UnitedHealth Group Incorporated (NYSE:UNH) stock presents a buying opportunity or has it become a value trap. In response, Cramer said: 'Look, I think, now this is a really tricky one because my rules say that even if I like that stock, and I gotta tell you, I think that Mr. Hemsley is fantastic, even if I like that stock, if there is a Justice Department inquiry, if there are problems with the government, I have to take a pass. Because more often than not, I've been hurt when I speculate.' A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group (NYSE:UNH) is a healthcare company that provides health plans, care services, pharmacy benefits, and health management programs. The company also offers software, data solutions, and consulting to healthcare organizations. Appearing on Squawk on the Street on May 21, Cramer said: 'Oh UNH is up… The things that they, I mean I thought that this was about as strongly denied, they've not denied the other stuff… Oh the HSBC, that's really early… Well Mr. Hemsley bought so much stock. You see those insider buys, from smart people. Those are not idle. It's not an idle buy. . .I think Hemsley's money. He's money. He's very good.' Overall, UNH ranks 3rd on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of UNH as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
